Lindsay Schock
Psychiatric/Mental Health · Cedar Rapids, IANPI 1457007270
Payments from drug & device makers
Across 141 payments — averaging $13.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$485
- AbbVie$449
- Otsuka America Pharmaceutical, Inc.$176
- Ironshore Pharmaceuticals Inc.$158
- Corium, LLC$152
- Axsome Therapeutics, Inc.$150
- plus $373 from 9 others
What the payments were for
- Food & beverage$1,89798%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $485 |
| AbbVie | 50 | $449 |
| Otsuka America Pharmaceutical, Inc. | 10 | $176 |
| Ironshore Pharmaceuticals Inc. | 9 | $158 |
| Corium, LLC | 13 | $152 |
| Axsome Therapeutics, Inc. | 8 | $150 |
| Lundbeck LLC | 5 | $106 |
| Alkermes, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Almatica Pharma LLC | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Tris Pharma Inc | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
How this compares
$1,944 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $17,077 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 20 | $626 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $133 |
| Zolpidem Tartrate | 12 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $449 | $17,07712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Cedar Rapids
- Jennifer BradleyCedar Rapids$66K
- Amy MorinCedar Rapids$24K
- Abbie KelleyCedar Rapids$7K
- Natasha LashCedar Rapids$6K
- Kristina GatesCedar Rapids$6K
- Daniell DarbyshireCedar Rapids$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.